US Broker Ratings

Krystal Biotech, Inc. (KRYS) Stock Analysis: 24.45% Potential Upside Sparks Investor Interest

Krystal Biotech, Inc. (NASDAQ: KRYS), a dynamic player in the biotechnology sector, is drawing significant attention from investors with a market cap of $7.36 billion and a compelling 24.45% potential..

Integer Holdings Corporation (ITGR) Stock Analysis: Assessing the 10.88% Potential Upside in the Medical Device Sector

Integer Holdings Corporation (NYSE: ITGR), a prominent player in the healthcare sector, specializes in the development and manufacturing of medical devices across its various global locations. With a market capitalization..

Regencell Bioscience Holdings (RGC): Analyzing the $13.53 Billion Market Cap in the TCM Sector

For investors seeking opportunities in the healthcare sector, particularly within the realm of Traditional Chinese Medicine (TCM), Regencell Bioscience Holdings Limited (NASDAQ: RGC) deserves a closer look. Based in Hong..

Inspire Medical Systems, Inc. (INSP): Growth Potential in Innovative Sleep Apnea Solutions with a 43.60% Upside

Inspire Medical Systems, Inc. (NASDAQ: INSP), a prominent player in the healthcare sector, is making waves in the medical devices industry with its cutting-edge solutions for obstructive sleep apnea (OSA)...

Globus Medical, Inc. (GMED) Stock Analysis: Unveiling a 26.72% Potential Upside for Investors

Globus Medical, Inc. (NYSE: GMED) stands out in the medical devices industry with its robust portfolio of healthcare solutions aimed at treating musculoskeletal disorders. As a key player in the..

Rhythm Pharmaceuticals (RYTM) Stock Analysis: 57% Upside Potential Amidst Strong Buy Ratings

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM), a commercial-stage biopharmaceutical company, is making waves in the biotechnology sector with a compelling 57.35% potential upside. With a market capitalization of $5.97 billion, Rhythm..

Telix Pharmaceuticals Limited (TLX) Stock Analysis: Unveiling a 141.96% Upside Potential

Telix Pharmaceuticals Limited (ASX: TLX) is capturing the attention of investors with its strategic positioning in the healthcare sector, particularly within the dynamic biotechnology industry. Based in North Melbourne, Australia,..

Penumbra, Inc. (PEN) Stock Analysis: Evaluating the 7.23% Upside Potential Amidst Robust Revenue Growth

Investors seeking opportunities in the healthcare sector may find Penumbra, Inc. (NYSE: PEN) a compelling prospect. This U.S.-based medical device company, with a market capitalization of $13.18 billion, is renowned..

Elanco Animal Health (ELAN) Stock Analysis: A 20% Upside Potential Amid Robust Revenue Growth

Elanco Animal Health Incorporated (NYSE: ELAN), a formidable player in the healthcare sector focusing on drug manufacturing for specialty and generic markets, is currently drawing investor attention with its promising..

Medpace Holdings, Inc. (MEDP) Stock Analysis: Promising Growth with a 32% Revenue Surge

Medpace Holdings, Inc. (NASDAQ: MEDP) stands out in the healthcare sector with its impressive growth trajectory, driven by a robust 32% increase in revenue. As a premier provider of clinical..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Exploring the 23% Upside Potential for Investors

Sarepta Therapeutics, Inc. (NASDAQ: SRPT) stands as a notable player in the biotechnology sector, primarily focusing on developing RNA-targeted therapeutics and gene therapies for rare diseases. With a market capitalization..

West Pharmaceutical Services (WST) Stock Analysis: A 34% Potential Upside in the Healthcare Sector

West Pharmaceutical Services, Inc. (NYSE: WST), a prominent player in the healthcare sector, is garnering increased attention from investors due to its robust growth potential and attractive valuation metrics. Operating..

Encompass Health Corporation (EHC) Stock Analysis: Potential 48.89% Upside Beckons Investors

Investors seeking opportunities in the healthcare sector might find Encompass Health Corporation (NYSE: EHC) a compelling prospect. With a market capitalization of $9.65 billion, this Birmingham, Alabama-based company stands out..

TransMedics Group, Inc. (TMDX) Stock Analysis: A 39.52% Upside Potential in Healthcare Innovation

TransMedics Group, Inc. (NASDAQ: TMDX) is carving out a significant niche within the medical devices sector, specifically targeting the transformative corner of organ transplant therapy. With a market capitalization of..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: A 46.83% Potential Upside Sparks Investor Interest

BridgeBio Pharma, Inc. (NASDAQ: BBIO), a pioneering player in the biotechnology sector, is capturing investor attention with its potential 46.83% upside, as indicated by its average target price of $100.64...

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: A 216% Upside Potential in the Biotech Sector

Soleno Therapeutics, Inc. (NASDAQ: SLNO), a biopharmaceutical company based in Redwood City, California, has captured the attention of investors in the biotechnology sector. With a market capitalization of $1.78 billion,..

Waystar Holding Corp. (WAY) Stock Analysis: Exploring a 52% Upside Potential in Healthcare Tech

As investors navigate the expansive healthcare sector, Waystar Holding Corp. (NASDAQ: WAY) emerges as a noteworthy contender, driven by its robust technology solutions for healthcare payments. With a market capitalization..

Halozyme Therapeutics (HALO) Stock Analysis: A Biotech Powerhouse with 33% Upside Potential

Halozyme Therapeutics, Inc. (NASDAQ: HALO), a frontrunner in the biotechnology sector, is garnering significant attention from investors due to a remarkable 33.22% potential upside, as indicated by analyst target prices...

Oscar Health, Inc. (OSCR) Stock Analysis: A Healthcare Player with a 21.93% Upside Potential

Oscar Health, Inc. (NYSE: OSCR), a key player in the U.S. healthcare plans sector, is drawing attention from investors with its innovative approach and a notable potential upside of 21.93%...

Bausch + Lomb Corporation (BLCO) Stock Analysis: Unlocking an 18.59% Upside in Eye Health Innovation

In the ever-evolving landscape of healthcare, Bausch + Lomb Corporation (NYSE: BLCO) stands as a beacon of innovation and expertise within the medical instruments and supplies industry. With a rich..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds